Safety and efficacy of anticoagulation therapy post atrial fibrillation ablation

9 March 2024 (15:35 - 16:20)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Athina Mpatsouli

Evangelismos Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail

Comprehensive atrial fibrillation package of care to minimise unnecessary hospital admission and improve patient outcome: a quality improvement project

Doctor M. Ohn (London, GB)

Abstract Slides

Presentation thumbnail

The role of rhythm control in patients with first diagnosed atrial fibrillation in a real world collective

Doctor B. Milles (Heidelberg, DE)

Abstract Slides

Presentation thumbnail

Does dysautonomia contribute to inappropriate sinus tachycardia in patients with post-COVID-19 syndrome?

Miss P. Bareke (London, GB)

Abstract Slides

Presentation thumbnail

Stratification of arrhythmic risk in patients admitted for acute coronary syndrome: the role of the machine learning-derived PRAISE score

Doctor A. Giubertoni (Novara, IT)

Abstract Slides

Access the full session

Session thumbnail

Assessment and management of acute rhythm disturbances

The Event

Event poster

ESC Acute CardioVascular Care 2024

9 March 2024 15:35 CET

You may be interested in

Congress Presentation

Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis

Congress Presentation

Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry

Congress Presentation

Anticoagulation management in post-operative atrial fibrillation during cardiac rehabilitation: a real-world perspective

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources